logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5662.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5662.produseast1
Showing 1 - 20 of 335 Items
Showing 1 - 20 of 335 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Dolutegravir resistance in Mozambique: Insights from a programmatic HIV resistance testing intervention in a highly antiretroviral therapy-experienced cohort

Ruano M, Flores A, Couto A, Gaspar I, Yerly S,  et al.
2025-09-30 • Infectious Disease Reports
2025-09-30 • Infectious Disease Reports

BACKGROUNDS

Treatment failure continues to play a role in HIV-related morbidity in Mozambique. Antiretroviral therapy (ART) regimen switches are decided empiric...

Journal Article
|
Research
Journal Article
|
Review
Journal Article
|
Research
Journal Article
|
Review
Journal Article
|
Review
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Review
Conference Material
|
Poster
Conference Material
|
Poster
Conference Material
|
Slide Presentation
Conference Material
|
Video

Antibiotic susceptibility patterns of bacterial pathogens isolated from hospitalized patients with advanced HIV disease (AHD) in Bihar, India

Murali S
2024-10-24 • MSF Scientific Days Asia 2024
2024-10-24 • MSF Scientific Days Asia 2024
Journal Article
|
Research
Journal Article
|
Review
Journal Article
|
Research
Journal Article
|
Letter
Journal Article
|
Research
Journal Article
|
Research

Acquisition of Escherichia coli carrying extended-spectrum ß-lactamase and carbapenemase genes by hospitalised children with severe acute malnutrition in Niger

Sands K, Lankapalli AK, Lai G, Hassan B, Portal EA,  et al.
2025-08-01 • Nature Communications
2025-08-01 • Nature Communications

Hospitalisation and routine antibiotic treatment are recommended for children with complicated severe acute...

Optimal dosing and duration of linezolid for the treatment of multidrug-resistant and rifampicin-resistant tuberculosis: An individual patient data meta-analysis

Kwak N, Kim JY, Han A, Berry C, Beumont M,  et al.
2025-07-17 • European Respiratory Journal
2025-07-17 • European Respiratory Journal

BACKGROUND

The optimal dosing strategy of linezolid for treating multidrug-resistant and rifampicin-resistant tuberculosis (MDR/RR-TB) remains unclear. We condu...

Bedaquiline, delamanid, linezolid, and clofazimine for rifampicin-resistant and fluoroquinolone-resistant tuberculosis (endTB-Q): an open-label, multicentre, stratified, non-inferiority, randomised, controlled, phase 3 trial

Guglielmetti L, Khan U, Velásquez GE, Gouillou M, Ali MH,  et al.
2025-07-16 • Lancet Respiratory Medicine
2025-07-16 • Lancet Respiratory Medicine

Clinical best practices for caring for people with expanded resistance to newer TB drugs

Nkomo T, Udwadia Z, Vambe D, van Rie A, Thi S,  et al.
2025-06-13 • IJTLD OPEN
2025-06-13 • IJTLD OPEN

BACKGROUND

Strains of Mycobacterium tuberculosis

Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosis

Seddon JA, Achar J, Malik AA, Hughes J, Burzynski J,  et al.
2025-06-06 • Lancet Infectious Diseases
2025-06-06 • Lancet Infectious Diseases

Phenotypic and genotypic resistance to bedaquiline in patients with multi-drug-resistant tuberculosis—experiences from Armenia

Ardizzoni E, Mulders W, De Diego Fuertes M, Hayrapetyan A, Mirzoyan A,  et al.
2025-04-09 • Antimicrobial Agents and Chemotherapy
2025-04-09 • Antimicrobial Agents and Chemotherapy

Risk factors for baseline bedaquiline (BDQ) resistance, amplification during treatment, and correlations with treatment outcomes are not fully understood. This cohort included Armenia...

Bedaquiline resistance and treatment outcomes among patients with tuberculosis previously exposed to bedaquiline in India: A multicentric retrospective cohort study

Singla R, Khan S, Silsarma A, Chavan V, Mahajan R,  et al.
2025-03-13 • Clinical Infectious Diseases
2025-03-13 • Clinical Infectious Diseases

BACKGROUND

Bedaquiline (BDQ) resistance presents a critical challenge in the fight against tuberculosis (TB), particularly multidrug-resistant (MDR) strains. Th...

The effectiveness and safety of bedaquiline, pretomanid, and linezolid (BPaL)-based regimens for rifampicin-resistant tuberculosis in non-trial settings - A prospective cohort study in Belarus and Uzbekistan

Sinha A, Klebe R, Rekart ML, Alvarez JL, Skrahina A,  et al.
2025-02-18 • Clinical Infectious Diseases
2025-02-18 • Clinical Infectious Diseases

BACKGROUND

Only 63% of patients initiating multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) treatment in 2020 were treated successfully. 24-Wee...

Antibiotic resistance in the Middle East and Southern Asia: a systematic review and meta-analysis

Mathu R, Diago-Navarro E, Lynch E, Degail MA, Ousley J,  et al.
2024-12-26 • JAC-Antimicrobial Resistance
2024-12-26 • JAC-Antimicrobial Resistance

INTRODUCTION

Despite global surveillance efforts, antibiotic resistance (ABR) is difficult to address in low- and middle-income countries (LMICs). In the absenc...

Antibiotic susceptibility patterns of bacterial pathogens isolated from hospitalized patients with advanced HIV disease (AHD) in Bihar, India

Kumar V, Murali S, Goldberg J, Alonso B, Moretó-Planas L,  et al.
2024-11-08 • MSF Scientific Days Asia 2024
2024-11-08 • MSF Scientific Days Asia 2024

Does antibiotic resistance really contribute to mortality among patients with gram-negative blood stream infections: A real world single center study

Bansal N
2024-11-08 • MSF Scientific Days Asia 2024
2024-11-08 • MSF Scientific Days Asia 2024

Antibiotic smart community project

Ali HM
2024-11-08 • MSF Scientific Days Asia 2024
2024-11-08 • MSF Scientific Days Asia 2024

Posttraumatic pseudomonas aeruginosa osteomyelitis in Mosul and Gaza: A retrospective cohort study, 2018-2022

Taher AQM, Aqel R, Alnajjar M, Walker C, Repetto E,  et al.
2024-09-27 • Open Forum Infectious Diseases
2024-09-27 • Open Forum Infectious Diseases

BACKGROUND

The history of conflicts in the Middle East has resulted in a high burden...

Are C-reactive protein and procalcitonin safe and useful for antimicrobial stewardship purposes in patients with COVID-19? A scoping review

Williams A, Repetto E, Lebbie I, Khalife M, Jensen TO
2024-09-24 • Cambridge Quarterly of Healthcare Ethics
2024-09-24 • Cambridge Quarterly of Healthcare Ethics

OBJECTIVE

The ...

How did the COVID-19 pandemic affect antibiotic consumption within humanitarian emergencies? Results from five humanitarian contexts

Yavuz T, Clezy K, Skender K, Goldberg J, Vallieres F
2024-09-01 • Infection Prevention in Practice
2024-09-01 • Infection Prevention in Practice

INTRODUCTION

Both ...

Pregnancy outcomes in multidrug-resistant tuberculosis in TB-PRACTECAL

Crocker-Buque T, Lachenal N, Narasimooloo C, Abdrasuliev T, Parpieva N,  et al.
2024-08-15 • Clinical Infectious Diseases
2024-08-15 • Clinical Infectious Diseases

Antibiotic consumption in hospitals in humanitarian settings in Afghanistan, Bangladesh, Democratic Republic of Congo, Ethiopia and South Sudan

Skender K, Versace G, Lenglet AD, Clezy K
2024-08-15 • Antimicrobial Resistance and Infection Control
2024-08-15 • Antimicrobial Resistance and Infection Control

BACKGROUND

Antimicrobial resistance is of great global public health concern. In order to address the paucity of antibiotic consumption data and antimicrobial resistance surveil...

Extensively antibiotic-resistant bacterial infections in trauma cases managed at the Médecins Sans Frontières tertiary orthopaedic center in Mosul, Iraq: A case series

Abdulrahman Ahmed H, Hasheem Mahmood H, Hosam Aldin Sami H, Natiq Taher A, Garcia-Vello P,  et al.
2024-07-08 • Open Forum Infectious Diseases
2024-07-08 • Open Forum Infectious Diseases

The Médecins Sans Frontières Tertiary Orthopaedic Care center in Mosul, Iraq, provides reconstructive surgery, microbiological analysis, integrated infection prevention and control, a...